DaVita Net Debt vs Short Long Term Debt Analysis
DVA Stock | USD 135.88 0.03 0.02% |
DaVita HealthCare financial indicator trend analysis is much more than just examining DaVita HealthCare latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether DaVita HealthCare is a good investment. Please check the relationship between DaVita HealthCare Net Debt and its Short Long Term Debt accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
Net Debt vs Short Long Term Debt
Net Debt vs Short Long Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of DaVita HealthCare Net Debt account and Short Long Term Debt. At this time, the significance of the direction appears to have almost no relationship.
The correlation between DaVita HealthCare's Net Debt and Short Long Term Debt is 0.15. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Short Long Term Debt in the same time period over historical financial statements of DaVita HealthCare Partners, assuming nothing else is changed. The correlation between historical values of DaVita HealthCare's Net Debt and Short Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of DaVita HealthCare Partners are associated (or correlated) with its Short Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Long Term Debt has no effect on the direction of Net Debt i.e., DaVita HealthCare's Net Debt and Short Long Term Debt go up and down completely randomly.
Correlation Coefficient | 0.15 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Net Debt
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.Short Long Term Debt
The total of a company’s short-term and long-term borrowings.Most indicators from DaVita HealthCare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into DaVita HealthCare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. At present, DaVita HealthCare's Discontinued Operations is projected to increase significantly based on the last few years of reporting. The current year's Tax Provision is expected to grow to about 235.8 M, whereas Selling General Administrative is forecasted to decline to about 797.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 3.6B | 3.4B | 3.1B | 2.1B | Total Revenue | 11.6B | 11.6B | 12.1B | 7.1B |
DaVita HealthCare fundamental ratios Correlations
Click cells to compare fundamentals
DaVita HealthCare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
DaVita HealthCare fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 17.3B | 17.0B | 17.1B | 16.9B | 17.6B | 10.2B | |
Short Long Term Debt Total | 11.2B | 11.2B | 12.0B | 11.8B | 11.1B | 5.7B | |
Other Current Liab | 756.2M | 810.5M | 709.3M | 730.4M | 1.6B | 1.7B | |
Total Current Liabilities | 2.4B | 2.5B | 2.4B | 2.6B | 2.6B | 1.6B | |
Total Stockholder Equity | 2.1B | 1.4B | 755.5M | 712.3M | 1.1B | 1.9B | |
Property Plant And Equipment Net | 6.3B | 6.4B | 6.3B | 5.9B | 5.6B | 5.9B | |
Net Debt | 10.1B | 10.9B | 11.5B | 11.6B | 10.7B | 11.2B | |
Retained Earnings | 1.4B | 852.5M | 354.3M | 174.5M | 598.3M | 568.4M | |
Accounts Payable | 403.8M | 434.3M | 402.0M | 479.8M | 514.5M | 284.0M | |
Cash | 1.1B | 325.0M | 461.9M | 244.1M | 464.6M | 453.4M | |
Non Current Assets Total | 13.6B | 13.8B | 14.0B | 13.8B | 14.5B | 7.6B | |
Non Currrent Assets Other | (461.6M) | (730.1M) | (694.3M) | (467.2M) | 236.8M | 248.7M | |
Cash And Short Term Investments | 1.1B | 345.1M | 484.2M | 321.8M | 476.2M | 504.8M | |
Net Receivables | 2.3B | 2.4B | 2.4B | 2.6B | 2.4B | 1.4B | |
Common Stock Shares Outstanding | 153.8M | 122.6M | 109.9M | 95.8M | 93.2M | 149.6M | |
Liabilities And Stockholders Equity | 17.3B | 17.0B | 17.1B | 16.9B | 17.6B | 10.2B | |
Non Current Liabilities Total | 11.4B | 11.6B | 12.4B | 12.1B | 12.2B | 6.1B | |
Inventory | 97.9M | 111.6M | 107.4M | 109.1M | 143.1M | 83.8M | |
Other Current Assets | 173.2M | 253.2M | 165.6M | 78.8M | 102.6M | 97.8M | |
Other Stockholder Equity | 749.0M | 597.1M | 540.3M | 606.9M | 509.8M | 367.2M | |
Total Liab | 13.8B | 14.1B | 14.8B | 14.7B | 14.9B | 7.7B | |
Total Current Assets | 3.7B | 3.1B | 3.2B | 3.2B | 3.1B | 2.6B | |
Short Term Debt | 474.6M | 538.0M | 573.4M | 626.8M | 517.7M | 543.6M | |
Intangible Assets | 135.7M | 166.6M | 177.7M | 182.7M | 203.2M | 193.1M | |
Property Plant And Equipment Gross | 6.3B | 6.4B | 11.1B | 11.2B | 11.3B | 11.9B | |
Accumulated Other Comprehensive Income | (47.5M) | (66.2M) | (139.2M) | (69.2M) | (52.1M) | (54.7M) | |
Common Stock Total Equity | 126K | 110K | 97K | 90K | 103.5K | 149.1K | |
Common Stock | 126K | 110K | 97K | 90K | 89K | 147.1K | |
Other Liab | 738.4M | 959.7M | 950.1M | 888.0M | 1.0B | 1.1B | |
Other Assets | 91.5M | 79.5M | 136.7M | 1K | 900.0 | 855.0 | |
Long Term Debt | 8.0B | 7.9B | 8.7B | 8.7B | 8.3B | 6.2B | |
Property Plant Equipment | 3.5B | 3.5B | 3.5B | 3.3B | 3.7B | 2.0B | |
Good Will | 6.8B | 6.9B | 7.0B | 7.1B | 7.1B | 6.3B | |
Short Term Investments | 11.6M | 20.1M | 22.3M | 77.7M | 11.6M | 11.0M | |
Net Tangible Assets | (3.6B) | (4.4B) | (5.0B) | (5.2B) | (4.7B) | (4.9B) | |
Noncontrolling Interest In Consolidated Entity | 185.8M | 183.2M | 180.6M | 163.6M | 147.2M | 139.8M | |
Retained Earnings Total Equity | 1.4B | 852.5M | 354.3M | 174.5M | 157.0M | 149.2M |
Pair Trading with DaVita HealthCare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DaVita HealthCare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DaVita HealthCare will appreciate offsetting losses from the drop in the long position's value.Moving together with DaVita Stock
0.93 | ELMD | Electromed | PairCorr |
Moving against DaVita Stock
0.79 | FNA | Paragon 28 | PairCorr |
0.77 | MGRM | Monogram Orthopaedics | PairCorr |
0.76 | NARI | Inari MedicalInc | PairCorr |
0.72 | NPCE | Neuropace Downward Rally | PairCorr |
0.69 | IART | Integra LifeSciences | PairCorr |
The ability to find closely correlated positions to DaVita HealthCare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DaVita HealthCare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DaVita HealthCare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DaVita HealthCare Partners to buy it.
The correlation of DaVita HealthCare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DaVita HealthCare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DaVita HealthCare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DaVita HealthCare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for DaVita Stock analysis
When running DaVita HealthCare's price analysis, check to measure DaVita HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DaVita HealthCare is operating at the current time. Most of DaVita HealthCare's value examination focuses on studying past and present price action to predict the probability of DaVita HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DaVita HealthCare's price. Additionally, you may evaluate how the addition of DaVita HealthCare to your portfolios can decrease your overall portfolio volatility.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is DaVita HealthCare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DaVita HealthCare. If investors know DaVita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DaVita HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.12 | Earnings Share 8.83 | Revenue Per Share 136.922 | Quarterly Revenue Growth 0.069 | Return On Assets 0.0636 |
The market value of DaVita HealthCare is measured differently than its book value, which is the value of DaVita that is recorded on the company's balance sheet. Investors also form their own opinion of DaVita HealthCare's value that differs from its market value or its book value, called intrinsic value, which is DaVita HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DaVita HealthCare's market value can be influenced by many factors that don't directly affect DaVita HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DaVita HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if DaVita HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DaVita HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.